Kentucky

NO
Registered Patient Population

0%
of Total Population Represented by Patients

N/A
Average Price Per 1/8

N/A
Average Price Per Gram Cannabis Oil

0
Total Medical Retail Locations Currently in Operation

N/A
Ratio of Patients to Retail Location

There is limited medical cannabis availability in Kentucky. The program limits patients to cannabidiol preparations with 0.3 percent or less THC, in compliance with USDA hemp standards. The state has yet to authorize CBD product production or distribution.

Patient Rights and Civil Protection

41/100

Access to Medicine

10/100

Functionality

28/100

Consumer Safety and Provider Requirements

0/100

Dispensing	0/25
Staff Training	0/5
Standard Operating Procedures	0/5
– Facility Sanitary Conditions	0/1.25
– Storage Protocols	0/1.25
– Reasonable Security Protocols	0/1.25
– Inventory Control	0/1.25
Recall Protocol and Adverse Event Reporting	0/5
Product Labeling	0/5
– Product Contents, Including Source Material Identification	0/1.67
– Allergens	0/1.67
– Potency/Compound Identification	0/1.67
Required Testing	0/5
– Active Compound Identification	0/1.67
– Contaminants	0/1.67
– Potency	0/1.67
Grow/Cultivation	0/25
Staff Training	0/5
Standard Operating Procedures	0/5
– Facility and Equipment Sanitary Conditions	0/0.71
– Workforce Safety Protocols	0/0.71
– Storage Protocols (Short-Term and Long-Term Storage)	0/0.71
– Reasonable Security Protocols	0/0.71
– Batch and Lot Tracking	0/0.71
– Disposal/Waste	0/0.71
– Water Management	0/0.71
Pesticide Guidance	0/5
– Pesticide Guidance	0/2.5
– Pesticide Labeling	0/2.5
Required Testing	0/5
– Active Ingredient Identification	0/1.25
– Contaminants	0/1.25
– Potency	0/1.25
– Sample Retention	0/1.25
Recall Protocol and Adverse Event Reporting	0/5
Manufacturing	0/25
Staff Training	0/5
Standard Operating Procedures	0/5
– Facility and Equipment Sanitary Conditions	0/1
– Workforce Safety Protocols	0/1
– Storage Protocols	0/1
– Reasonable Security Protocols	0/1
– Batch and Lot Tracking	0/1
Product Labeling	0/5
– Product Contents, Including Source Material Identification	0/1.67
– Allergens	0/1.67
– Potency and Compound Information	0/1.67
Required Testing	0/5
– Active Ingredient Identification	0/1
– Contaminants	0/1
– Potency	0/1
– Shelf Life Testing	0/1
– Sample Retention	0/1
Recall Protocol and Adverse Event Reporting	0/5
Laboratory Operations	0/25
Staff Training	0/5
Method Validation in Accordance with AHP Guidelines	0/5
Result Reporting	0/5
Independent or Third Party	0/5
Standard Operating Procedures and Protocols	0/5
– Equipment and Instrument Calibration	0/0.83
– Sample Tracking	0/0.83
– Facility and Equipment Sanitary Conditions	0/0.83
– Disposal/Waste	0/0.83
– Storage Protocols	0/0.83
– Workforce Safety Protocols	0/0.83

Covid Response

0/20

Excerpted from ASA's 2020 State of the States Report.

In This Section

Kentucky Medical Marijuana Laws and Regulations

In 2014, the Kentucky legislature revised the definition of marijuana under state law to create legal protection for patients who use a cannabidiol (CBD) medicine as part of an approved clinical trial or on the written order of “a physician practicing at a hospital or associated clinic affiliated with a Kentucky public university having a college or school of medicine.”